When #WHAuden invited Austrian friends to come to #NYC in the mid-1960s, he reminded them to bring a vaccination certificate. đ
Would this most likely refer to #smallpox vaccine? #Tubercolosis? #Poliomyelitis?
Currently watching back-to-back:
⢠Crash Course: Tubercolosis, and
⢠SciShow: Cancer
âď¸ https://youtu.be/7D-gxaie6UI (50 minutes)
âď¸ https://youtu.be/GkxrJSTLH_s (74 minutes)
#fz_webVideos #fz_currentAffairs #tubercolosis #cancer #PartnersInHealth #DoctorsWithoutBorders #Nerdfighteria #CrashCourse #SciShow
A vaccine against tuberculosis, the worldâs deadliest infectious disease, has never been closer to reality, with the potential to save millions of lives. But its development slowed after its corporate owner focused on more profitable vaccines.
https://youtube.com/watch?v=tSC06P9A5W4
Under our current system, companies like #Danaher have to pursue #profit over #people. It's #TimeForFive on cartridges for the #Cepheid #GeneXpert to identify drug resistant #tubercolosis. Price gouging companies that brag about using the printer ink or disposable razor model to squeeze desperate sick people need to get the hammer.
These vultures are profiting from public investments in health, not from taking risks. That's our intellectual property, paid for with our taxes. Give it back!
The #StopTB partnership released a statement this morning saying #JohnsonAndJohnson has allowed them to produce generic #bedaquiline and make it available in most developing countries, even in those where the secondary patent is still in effect.
While J&J havenât released their own statement yet, and this isnât a complete dropping of their patent, this is a huge step forward in ending TB and deserves to be celebrated.
#PatientsNotPatents #tubercolosis #EndTB
https://www.stoptb.org/news/global-drug-facility-update-access-to-bedaquiline
13 July 2023 Following lengthy negotiations, Johnson & Johnson has granted Stop TB Partnership´s Global Drug Facility`s licenses that enable Global Drug Facility (GDF) to tender, procure, and supply generic versions of SIRTUROŽ (bedaquiline) for the majority of low-and middle-income countries, including countries where patents remain in effect. GDF has shared with the TB
Johnson & Johnson forsøker seg med sekundÌrpatentar pü tuberkolosemedisinen #bedaquiline for ü potensielt kunne halde pü eineretten til ü produsere medisinen i (minst) 4 ür til.
Noko dei veit kjem til ü føre til at tusenvis døyr av ein veldig kurerbar sjukdom fordi dei ikkje har rüd til kuren.
Forklart meir i detalj her av John Green: https://www.youtube.com/watch?v=tMhgw5SW0h4 #dftba #patent #tubercolosis #JNJ #johnsonandjohnsongreed